Результати пошуку - Laura M. Spring

Уточнити результати
  1. 1
    The Evolving Role of Neoadjuvant Therapy for Operable Breast Cancer

    The Evolving Role of Neoadjuvant Therapy for Operable Breast Cancer за авторством Laura M. Spring, Yael Bar, Steven J. Isakoff

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations

    Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations за авторством Laura M. Spring, Mark L. Zangardi, Beverly Moy, Aditya Bardia

    Опубліковано 2017
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  3. 3
    Impact of pass/fail grading on medical students’ well-being and academic outcomes

    Impact of pass/fail grading on medical students’ well-being and academic outcomes за авторством Laura M. Spring, Diana Robillard, Lorrie Gehlbach, Tiffany A. Moore Simas

    Опубліковано 2011
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  4. 4
    CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions

    CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions за авторством Laura M. Spring, Seth A. Wander, Mark L. Zangardi, Aditya Bardia

    Опубліковано 2019
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  5. 5
    ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer

    ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer за авторством Jamie O. Brett, Laura M. Spring, Aditya Bardia, Seth A. Wander

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  6. 6
    Mechanisms of Resistance to CDK4/6 Blockade in Advanced Hormone Receptor–positive, HER2-negative Breast Cancer and Emerging Therapeutic Opportunities

    Mechanisms of Resistance to CDK4/6 Blockade in Advanced Hormone Receptor–positive, HER2-negative Breast Cancer and Emerging Therapeutic Opportunities за авторством Maxwell R. Lloyd, Laura M. Spring, Aditya Bardia, Seth A. Wander

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  7. 7
    Mechanisms of Resistance to Antibody–Drug Conjugates

    Mechanisms of Resistance to Antibody–Drug Conjugates за авторством Rachel O. Abelman, Bogang Wu, Laura M. Spring, Leif W. Ellisen, Aditya Bardia

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  8. 8
    Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

    Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer за авторством Laura M. Spring, Arjun Gupta, Kerry L. Reynolds, Michele A. Gadd, Leif W. Ellisen, Steven J. Isakoff, Beverly Moy, Aditya Bardia

    Опубліковано 2016
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  9. 9
    Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities

    Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities за авторством Laura M. Spring, Erika Nakajima, Jennifer Hutchinson, Elene Viscosi, Gayle C. Blouin, Colin D. Weekes, Hope S. Rugo, Beverly Moy, Aditya Bardia

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  10. 10
    Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer

    Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer за авторством Rosaria Condorelli, Laura M. Spring, Joyce O’Shaughnessy, Ludovic Lacroix, Caroline Bailleux, Véronique Scott, Jon S. Dubois, Rebecca J. Nagy, Richard B. Lanman, A. John Iafrate, Fabrice André, Aditya Bardia

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies

    Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies за авторством Yael Bar, Geoffrey Fell, Aylin S. Dedeoglu, Natalie Moffett, Neelima Vidula, Laura M. Spring, Seth A. Wander, Aditya Bardia, Naomi Y. Ko, Beverly Moy, Leif W. Ellisen, Steven J. Isakoff

    Опубліковано 2025
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis

    Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis за авторством Laura M. Spring, Geoffrey Fell, Andrea Arfè, Chandni Sharma, Rachel A. Greenup, Kerry L. Reynolds, Barbara L. Smith, Brian M. Alexander, Beverly Moy, Steven J. Isakoff, Giovanni Parmigiani, Lorenzo Trippa, Aditya Bardia

    Опубліковано 2020
    Отримати повний текст
    Carta
    Додати у Вибране
    Збережено в:
  13. 13
    Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer

    Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer за авторством Laura M. Spring, Rachel A. Greenup, Andrzej Niemierko, Lidia Schapira, Stephanie Haddad, Rachel Jimenez, Suzanne B. Coopey, Alphonse G. Taghian, Kevin S. Hughes, Steven J. Isakoff, Leif W. Ellisen, Barbara L. Smith, Michelle C. Specht, Beverly Moy, Aditya Bardia

    Опубліковано 2017
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  14. 14
    Neoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

    Neoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial за авторством Heather L. McArthur, J.H.S. Leal, David B. Page, Aditya Bardia, Laura M. Spring, Christina DiLauro Abaya, Reva Basho, Lindsey Ristow, Hannah Coleman, Stephen L. Shiao, Simon Knott, Mourad Tighiouart, Farnaz Dadmanesh, Sunil Verma, A. E. Giuliano

    Опубліковано 2019
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  15. 15
    A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

    A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer за авторством Tanya T. Kwan, Aditya Bardia, Laura M. Spring, Anita Giobbie‐Hurder, Mark Kalinich, Taronish D. Dubash, Tilak Sundaresan, Xin Hong, Joseph A. LiCausi, Uyen Ho, Erin J. Silva, Ben S. Wittner, Lecia V. Sequist, Ravi Kapur, David T. Miyamoto, Mehmet Toner, Daniel A. Haber, Shyamala Maheswaran

    Опубліковано 2018
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  16. 16
    <i>FGFR1</i> Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer

    <i>FGFR1</i> Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer за авторством Joshua Z. Drago, Luigi Formisano, Dejan Juric, Andrzej Niemierko, Alberto Servetto, Seth A. Wander, Laura M. Spring, Neelima Vidula, Jerry Younger, Jeffrey Peppercorn, Megan Yuen, Giuliana Malvarosa, Dennis C. Sgroi, Steven J. Isakoff, Beverly Moy, Leif W. Ellisen, A. John Iafrate, Carlos L. Arteaga, Aditya Bardia

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  17. 17
    Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy

    Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy за авторством Jason I. Griffiths, Jinfeng Chen, Patrick A. Cosgrove, Anne O’Dea, Priyanka Sharma, X. Cynthia, Meghna S. Trivedi, Kevin Kalinsky, Kari B. Wisinski, Ruth O’Regan, Issam Makhoul, Laura M. Spring, Aditya Bardia, Frederick R. Adler, Adam L. Cohen, Jeffrey T. Chang, Qamar J. Khan, Andrea H. Bild

    Опубліковано 2021
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  18. 18
    Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique

    Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique за авторством Emily J. Gallagher, Heather Moore, Mario E. Lacouture, Susan Dent, Azeez Farooki, Marcus D. Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura M. Spring, Brian Berman, Melanie Decker, Gabriel N. Hortobágyi, Benjamin H. Kaffenberger, Bernice Y. Kwong, Timothy Pluard, Ruta Rao, Lee S. Schwartzberg, Michael S. Broder

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  19. 19
    Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models

    Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models за авторством Ioanna Keklikoglou, Chiara Cianciaruso, Esra Güç, Mario Leonardo Squadrito, Laura M. Spring, Simon Tazzyman, Lore Lambein, Amanda Poissonnier, Gino B. Ferraro, Caroline Baer, Antonino Cassará, Alan Guichard, M. Luisa Iruela‐Arispe, Claire E. Lewis, Lisa M. Coussens, Aditya Bardia, Rakesh K. Jain, Jeffrey W. Pollard, Michele De Palma

    Опубліковано 2018
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  20. 20
    Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

    Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab за авторством Otto Metzger, Giuseppe Viale, Shayna Stein, Lorenzo Trippa, Denise A. Yardley, Ingrid A. Mayer, Vandana G. Abramson, Carlos L. Arteaga, Laura M. Spring, Adrienne G. Waks, Eileen Wrabel, Michelle K. DeMeo, Aditya Bardia, Patrizia DellʼOrto, Leila Russo, Tari A. King, Kornélia Polyák, Franziska Michor, Eric P. Winer, Ian E. Krop

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: